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ABSTRACT 21 
Lactococcin 972 (Lcn972) is a non-lantibiotic bacteriocin that inhibits cell wall biosynthesis 22 
by binding to lipid II. In this work, two mutants resistant to Lcn972 Lactococcus lactis D1 23 
and D1-20 have been isolated with a high (>320 arbitrary units (AU)/ml) and low (80 AU/ml) 24 
susceptibility, respectively. Resistance to Lcn972 did not impose a burden to growth under 25 
laboratory conditions nor did it substantially alter the physicochemical properties of the cell 26 
surface. However, the peptidoglycan of the mutants featured a higher content of muropeptides 27 
with tripeptide side-chains than the wild type strain, linking for the first time peptidoglycan 28 
remodelling to bacteriocin resistance. Moreover, L. lactis lacking a functional D,D-29 
carboxypeptidase DacA (i.e. with a high content of pentapeptide side chain muropeptides) 30 
were shown to be more susceptible to Lcn972. Cross-resistance to lysozyme and nisin and 31 
enhanced susceptibility to penicillin G and bacitracin was also observed. Intriguingly, the 32 
Lcn972 resistant mutants were not infected by the lytic phage c2 and less efficiently by phage 33 
sk1. Lack of c2 infectivity was linked to a 22.6 kbp chromosomal deletion encompassing the 34 
phage receptor protein pip. The deletion also included maltose metabolic genes and the two 35 
component system TCS F. However, a clear correlation between these genes and resistance to 36 
Lcn972 could not be clearly established, pointing to the presence of as yet unidentified 37 
mutations that account for Lcn972 resistance.  38 
 39 
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INTRODUCTION 43 
Lactococcus lactis is one of the main components of the mesophilic starter cultures used in 44 
cheese manufacturing. Thereby, there is a genuine interest in improving robustness to ensure 45 
the success of dairy fermentations. L. lactis performance may be compromised by the 46 
presence of bacteriophages or other inhibitors such as antibiotics, lysozyme or bacteriocins in 47 
raw milk (12, 27). Many of these antibacterial compounds target cell wall components. 48 
Bacteriophages recognize bacterial receptors, mostly of polysaccharide nature, prior to 49 
infection (37), while lysozyme acts directly on the cell wall peptidoglycan hydrolysing the 50 
glycosidic bonds between N-acetylmuramic acid and N-acetylglucosamine. Moreover, an 51 
increasing number of bacteriocins, antimicrobial peptides synthesized by bacteria, have been 52 
reported to inhibit cell wall biosynthesis by binding to the cell wall precursor lipid II, 53 
including the lactococcal lantibiotics nisin and lacticin 3147 and the non-lantibiotic 54 
lactococcin 972 (Lcn972) (4, 23, 42). 55 
As a Gram positive bacterium, the cell envelope of L. lactis consists of a cytoplasmic 56 
membrane and a thick cell wall. The cell wall is mostly composed of peptidoglycan (PG) 57 
made of glycan strands crosslinked by peptides, and secondary polymers such as teichoic 58 
acids, proteins and carbohydrates. L. lactis has an A4α-type peptidoglycan with an L-Ala-α-59 
D-Glu-L-Lys-D-Ala as the tetrapeptide and D-Asp in the interpeptide bridge (9). Recent 60 
microscopy advances have provided a very detailed knowledge on the PG structure in L. lactis 61 
cell wall (1, 41). 62 
The cell wall in Gram positive bacteria protect cells from osmotic pressure and acts as an 63 
exoskeleton maintaining cell shape and as scaffold for anchoring other cell envelope 64 
components (40 and references therein). Thus, monitoring its integrity is crucial for survival. 65 
In L. lactis, the response to cell envelope stress is governed by the two component system 66 
CesSR which has been shown to be triggered by lysozyme, nisin and Lcn972 (26, 39) and by 67 
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heterologous protein secretion and phage infection (11, 33). Although the CesR regulon is not 68 
fully understood, certain CesR-regulated components are known to contribute positively to L. 69 
lactis survival under technological relevant stresses (34). 70 
In this work, we have isolated L. lactis mutants resistant to Lcn972 (Lcn972R) which were 71 
characterized with a particular emphasis on cell surface properties, PG composition and 72 
resistance to cell wall active antimicrobials such as lysozyme and bacteriophages. Lcn972 is 73 
an atypical 66-aminoacid bacteriocin that does not meet the widely accepted criteria of small, 74 
heat-resistant hydrophobic peptides. Lcn972 is a highly hydrophilic cationic peptide easily 75 
inactivated by heat (25). In contrast to other lipid II-binding bacteriocins, Lcn972 does not 76 
form pores in the cytoplasmic membrane and is active exclusively against lactococci (23). 77 
These features make Lcn972 a unique candidate to shed light on mechanisms that help L. 78 
lactis to cope better with cell wall stress.  79 
 80 
MATERIAL AND METHODS 81 
Bacterial strains, bacteriophages, and growth conditions. L. lactis strains (Table 1) were 82 
routinely grown in M17 with glucose 0.5% (GM17), statically and at 30 ºC. When specified, 83 
glucose was replaced by maltose 0.5% (MM17) or Chemically Defined Medium (CDM) (29) 84 
was used. E. coli strains were grown in 2xYT (35) at 37 ºC with shaking. When needed, 85 
antibiotics erythromycin and ampicillin were used at a final concentration of 5 μg ml-1 and 86 
100 µg ml-1, respectively. Growth rates (μ) were calculated through linear regressions of the 87 
plots of ln(optical density at 600 nm, OD600) versus time during the exponential growth phase. 88 
Bacteriophages c2 and sk1 were propagated on L. lactis MG1614. Phage titer was calculated 89 
by the standard plate assay. Decimal dilutions in NaCl 0.9% of phage lysates were mixed with 90 
3.5 ml of molten GM17 0.7% agar supplemented with 10 mM CaCl2 and 100 μl of stationary 91 
phase L. lactis MG1614 culture. The mixture was spread on GM17 plates and incubated at 30 92 
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ºC for 16 h until clear lytic plaques were visible. Bacterial cultures were stored at -80 ºC in 93 
the appropriate medium and glycerol 10% (v/v). Phage lysates were stored at 4 ºC. 94 
 95 
Standard DNA techniques. Standard molecular techniques were followed as described 96 
elsewhere (35). Chromosomal DNA was isolated with GenElute Bacterial Genomic DNA Kit 97 
(Sigma-Aldrich, Spain). Restriction enzymes were purchased from Takara (Japan) and T4 98 
ligase from Fisher Scientific (Spain). Oligonucleotides were supplied by Sigma-Aldrich 99 
(Spain). Standard PCR reactions were carried out using PuRe Taq Ready-to-go PCR Beads 100 
(GE Healthcare, UK). For cloning purposes and PCRs expected to yield long products, the 101 
proof-reading Phusion High-Fidelity DNA Polymerase (Fisher Scientific, Spain) was used.  102 
 103 
Selection of L. lactis resistant to Lcn972. The bacteriocin Lcn972 was purified and 104 
quantified as described (26). Lcn972 dilutions were done in sodium phosphate buffer 50 mM, 105 
pH 6.8. To isolate Lcn972 resistant mutants, L. lactis MG1614 was cultivated step-wise in 106 
GM17 in the presence of increasing Lcn972 concentrations ranging from 5 AU/ml to up to 107 
400 AU/ml. Overnight cultures grown at the highest Lcn972 concentration were diluted and 108 
plated on GM17 to get isolated colonies. A single colony, designated L. lactis D1, was 109 
randomly selected. L. lactis D1-20 was colony-isolated after serial passages of L. lactis D1 in 110 
GM17 during 200 generations.  111 
 112 
Construction of L.lactis ΔdacA. The flanking 600 bp regions up- and downstream of dacA 113 
(llmg2560 in L. lactis MG1363; GenBank AM406671) were amplified and fused by SOE-114 
PCR (Splicing by Overlap Extension-PCR) using the primers D1 (5’ 115 
AACTGCAGTATTGACAAATGCCG 3’), D2 (5’ 116 
AAAAACTTTTGGAGCACTGACAGCAAAGCTCG 3’), D3 (5’ 117 
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AGTGCTCCAAAAGTTTTTTGG 3’), and D4 (5’ GAAGATCTGCTAAACGTGACCC 3’). 118 
The SOE-PCR fragment was cloned into the non-replicating plasmid pORI280 using the 119 
engineered restriction sites PstI and BglII in the far ends of primers D1 and D4, respectively, 120 
to generate the plasmid pBL16. Transformation of L. lactis NZ9000 and selection of deletion 121 
mutants proceeded according to Leenhouts et al. (22). 122 
 123 
Mapping chromosomal deletion in L. lactis D1 and D1-20. A forward primer 0734F (5’ 124 
GAAATGGCCCTGCGACGTGTAG 3’), located within the llmg0734 locus, was used in 125 
combination with the reverse 0752R (5’ CGCTGCATCCAATGTCACAGTC 3’) in pip for 126 
PCR amplification using L. lactis DNA. PCR conditions were: 98 ºC 30 sec; 35 cycles 98 ºC 127 
10 sec, 63 ºC 30 sec, 72 ºC 13 min; 72 ºC 10 min and Phusion High-Fidelity DNA 128 
Polymerase was used. PCR products were purified with Illustra GFX PCR DNA and Gel 129 
Band Purification Kit (GE Healthcare, UK) and sequenced. Southern hybridization was 130 
carried out on 200 ng of total DNA digested with EcoRI and HindIII blotted to a nylon 131 
Hybond-N membrane (GE Healthcare, UK) (35). The DNA probe was labelled by PCR on L. 132 
lactis MG1614 DNA using primers pipF (5’ CGGATTCATCTATGTTGACC 3’) and pipR2 133 
(5’ AATTGCTTCTCTTTGTCGG 3’), expanding the 5’ end of pip (see Fig 3) and labelled 134 
dNTPs from PCR Dig Labelling Mix (Roche, Spain). PCR conditions were: 98 ºC 30 sec; 35 135 
cycles 98 ºC 10 sec, 45 ºC 30 sec, 72 ºC 2 min; 72 ºC, 10 min, using Phusion High-Fidelity 136 
DNA Polymerase. The blots were revealed by immunodetection at 20 ºC using CDP Star 137 
(Roche, Spain) following manufacturer’s recommendations. 138 
 139 
Surface properties. The electrophoretic mobility was measured using stationary phase 140 
cells concentrated to 107 cfu/ml in NaCl 5 mM as previously described (15). Hydrophobicity 141 
was determined following the microbial-adhesion-to-solvents method (MATS) using 142 
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hexadecane and stationary phase cells in NaCl 0.15 M adjusted to a final OD600nm of 0.8 (2). 143 
Each measurement was performed in triplicate and the assay was carried out twice with 144 
independent cultures. Adsorption of Lcn972 to lactococcal cells was performed by mixing 145 
200 µl of exponentially growing cells adjusted to an OD600 of 2.0 with 200 µl of Lcn972 20 146 
µg/ml in sodium phosphate buffer 50 mM, pH 6.8. Residual inhibitory activity was measured 147 
by the agar diffusion test using L. lactis MG1614 as indicator (26).  148 
 149 
Cell wall composition. Peptidoglycan (PG) preparations were obtained from 500 ml of 150 
exponentially growing (OD600 of 0.3) cultures as described previously (9). Briefly, after SDS-151 
lysis, the crude cell wall preparation containing PG was treated with 48 % hydrofluoric acid 152 
for 16 h at 4 °C to eliminate anionic polymers linked to PG. Two mg of purified PG were 153 
digested with mutanolysin (Sigma, 2500 U/ml) for 10 h at 37 °C under shaking. Solubilized 154 
muropeptides were reduced by sodium borohydride and separated by reverse phase high-155 
performance liquid chromatography (RP-HPLC) as described previously (9). The percentage 156 
of muropeptides with a certain peptide side chain (X = tri, tetra and penta) with free COOH 157 
(donor chain) was calculated according to Glauner et al. (16) as follows: percentage (X) = 158 
[Σmonomers(X) + ½ Σdimers(X) + 1/3 Σtrimers(X) + ¼ Σtetramers(X)]/  Σall muropeptides. 159 
During the isolation of PG, part of the cell wall fraction was kept before the treatment with 160 
hydrofluoric acid to determine the sugar composition (6). The cell wall fraction was 161 
hydrolyzed with TFA 4 M at 110 °C for 3 hours and derivatizated with N-methyl-N-162 
(trimethylsilyl)-trifluoroacetamide (MSTFA) for 30 min at room temperature and analyzed by 163 
gas chromatography coupled to mass spectrometry (6). The content of D-alanine esterified to 164 
teichoic acids was determined after release by alkaline hydrolysis from 10 mg of dried cells 165 
from 300 ml of stationary phase lactococcal cultures in GM17 as previously described (15).  166 
 167 
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Antimicrobial susceptibility assays. The susceptibility of L. lactis cell envelope mutants 168 
to Lcn972 was tested by the spot-on-the-lawn method. Overnight cultures were diluted 10-169 
fold in Ringer saline solution (Merck, Germany) and inoculated 1:1000 (v/v) in melted GM17 170 
containing 1.2 % agar. Drops (5 µl) of twofold dilutions of Lcn972 were spotted on the plates 171 
and incubated at 30 ºC. To determine cross-resistance to cell wall antimicrobials, serial 172 
dilutions in GM17 broth of L. lactis D1, D1-20 and the wild-type MG1614 overnight cultures 173 
were spotted on GM17 plates containing lysozyme 0.5 mg/ml, nisin 10 ng/ml, bacitracin 0.5 174 
µg/ml or penicillin G 0.05 µg/ml. Lcn972 minimal inhibitory concentration (MIC) were 175 
carried out in microtiter plates using either GM17 or MM17 essentially as described (5). 176 
 177 
Phage assays. The efficiency of plaquing (EOP) was defined as the phage titre on the 178 
tested strain divided by that on the reference L. lactis MG1614. Each c2 and sk1 phage 179 
suspensions were plated in triplicate. Phage adsorption was determined by mixing 180 
exponentially growing lactococcal cultures L. lactis MG1614, L. lactis D1 and L. lactis D1-20 181 
at OD600nm of 0.5 with c2 or sk1 phage suspensions to match a ratio phage/bacteria (MOI) of 182 
2x10-6 for c2 and 1x10-3 for sk1. After 10 min incubation at 30 ºC, samples were centrifuged 183 
and the phage titer of the supernatant was determined by the standard plaque assay using L. 184 
lactis MG1614 as host. The percentage of adsorption was determined as follows: 1-(phage 185 
titer of the supernatant/phage titer of a control tube without cells) x 100. The assay was 186 
carried out twice with independent cultures and plating was made in triplicate.  187 
 188 
RESULTS 189 
Isolation of L. lactis MG1614 resistant to Lcn972. Step-wise exposure of L. lactis MG1614 190 
to increasing Lcn972 concentrations resulted in cultures able to multiply in the presence of 191 
400 AU/ml of Lcn972. A single colony, designated L. lactis D1, was randomly selected. This 192 
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mutant was highly resistant to Lcn972 with a MIC over 320 AU/ml (Table 2). This high 193 
resistant phenotype was lost in the absence of selective pressure for 130 generations after 194 
which, a stable phenotype, L. lactis D1-20, with a MIC of 80 AU/ml (Table 2) could be 195 
maintained at least for 70 generations more.  196 
Resistance to Lcn972 did not clearly impose a burden to L. lactis as similar growth rates 197 
were observed in GM17 broth at 30 ºC (Table 2). However, under more limiting nutritional 198 
conditions in CDM-glucose, a decrease of 30% in the growth rate was observed for both 199 
Lcn972R mutants. Growth on galactose was seriously compromised in L. lactis D1 and 200 
maltose did not support growth (Table 2).  201 
 202 
Surface properties and cell wall composition of L. lactis MG1614 resistant to Lcn972. 203 
Physicochemical properties of the bacterial cell surface may determine the initial interaction 204 
of bacteriocins to the target cell and contribute to resistance. Indeed, adsorption of Lcn972 to 205 
Lcn972R cells was reduced by 50 % compared to the susceptible L. lactis MG1614 (Table 2). 206 
According to their electrophoretic mobility, L. lactis MG1614 and the mutants were equally 207 
negatively charged (data not shown) whereas the Lcn972R strains revealed a less hydrophobic 208 
character (P < 0.001) compared to L. lactis MG1614 (Table 2), anticipating subtle changes in 209 
the bacterial surface. 210 
As Lcn972 is active at the cell wall level (23), we looked for alterations in the structure and 211 
composition of the cell wall in the Lcn972R mutants. Macroscopically, cells grew in pairs and 212 
short chains irrespectively of their phenotype. Large ultra-structural changes such as a 213 
thickened cell wall or absence of the surface polysaccharide layer (6) were not observed by 214 
electron microscopy (data not shown). Likewise, the overall content of monosaccharides 215 
(glucose, galactose, rhamnose), amino sugars (glucosamine), glycerol and phosphate of the 216 
cell wall fraction of the strains did not reveal substantial differences among the strains (data 217 
10 
 
not shown). Teichoic acids, which can be D-alanylated to modulate the negative charges 218 
inside the cell wall, were also analyzed. Although the resistant mutants contained less D-Ala 219 
than the wild-type, the differences were not statistically significant (P > 0.05) (Table 2) 220 
suggesting that D-alanylation does not contribute largely to resistance to Lcn972. 221 
On the contrary, remarkable differences among the strains were observed when the soluble 222 
peptidoglycan muropeptides were analyzed. While similar percentages of mono-, di-, tri- and 223 
tetramers were found among the strains, both Lcn972R mutants D1 and D1-20 showed a 224 
higher content of muropeptides with tripeptide side chains and a reduced content of 225 
pentapeptide side chains compared to the wild-type (Fig. 1). This observation suggested an 226 
alteration in the Lcn972R mutants of activities involved in PG maturation.  227 
 228 
Susceptibility to Lcn972 of cell envelope L. lactis mutants. To test the putative role of 229 
the PG structure on the Lcn972 resistant phenotype, a cell envelope mutant L. lactis dacA was 230 
generated. dacA encodes a D-Ala-D-Ala carboxypeptidase putatively involved in trimming 231 
away the last D-Ala residue from the PG pentapeptide. The chromosomal deletion of dacA 232 
was confirmed by PCR and absence of the protein was evidenced by the lack of the respective 233 
bocillin FL-labelled 45 kDa protein band in membrane protein extracts analysed by SDS-234 
PAGE (data not shown). L. lactis dacA PG analysis revealed a dramatic decrease of 235 
muropeptides with tri- and tetrapeptide chains accompanied with a strong increase of 236 
muropeptides with pentapeptide side chains (Fig. 1), confirming a major role of DacA in PG 237 
maturation in L. lactis. 238 
L. lactis dacA and other available L. lactis defective in cell wall modification enzymes 239 
(Table 1) were screened for their susceptibility to Lcn972. L. lactis dltD lacking DltD, a 240 
membrane protein involved in LTA D-alanylation and L. lactis dacB lacking the D,L-241 
carboxypeptidase DacB, that cleaves the bond between L-Lys-D-Ala of the pentapeptide side 242 
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chain were assayed (Fig. 2). Despite the fact that no significant differences in the D-Ala 243 
content were observed among L. lactis MG1614 and strains D1 and D1-20, L. lactis dltD 244 
devoid of D-Ala showed a four-fold increased susceptibility to Lcn972. Higher susceptibility 245 
was also observed in the case of L. lactis dacA whereas L. lactis dacB showed no differences 246 
compared to the wild-type strain (Fig. 2). These results indicate that the high content of 247 
pentapeptide side chains present in dacA PG enhances the antimicrobial activity of Lcn972 248 
and correlated well with their decrease in the Lcn972 resistant mutants (Fig. 1).  249 
 250 
Cross-resistance to cell wall active antimicrobials. In order to ascertain if resistance to 251 
Lcn972 in L. lactis could interfere with the activity of other cell wall inhibitors, we checked 252 
the susceptibility profile of L. lactis D1, D1-20 and the parent MG1614 to lysozyme, that 253 
hydrolyses the PG sugar chains, bacitracin, that inhibits recycling of the PG lipid carrier, 254 
penicillin G that inhibits transpeptidation during the last stage of PG synthesis and nisin, a 255 
pore-forming bacteriocin that also prevents cell wall biosynthesis by binding to lipid II. Both 256 
Lcn972R strains were more resistant to lysozyme and nisin and more susceptible to bacitracin 257 
and penicillin G than L. lactis MG1614 (Fig. 2). It is worth noting that nisin resistance in L. 258 
lactis D1 was higher than D1-20, somewhat correlating with their resistance to Lcn972 (Table 259 
2). 260 
 261 
Resistance to bacteriophages. Although rarely addressed, resistance to phage infection 262 
has been observed in nisin resistant Staphylococcus aureus (24) and in a sakacin P resistant 263 
Listeria monocytogenes (36). Considering the negative impact of bacteriophages in industrial 264 
dairy fermentations, the Lcn972R strains were challenged with phages c2 and sk1, two lytic 265 
phages belonging to the c2 and 936 families, respectively, and commonly found in the dairy 266 
environment. As judged by the efficiency of plaquing (EOP) referred to L. lactis MG1614 as 267 
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control, L. lactis D1 and D1-20 were fully resistant to phage c2 (Table 3). Phage sk1 was still 268 
able to infect both Lcn972R mutants, although resistance to sk1infection was more 269 
pronounced in L. lactis D1, somewhat correlating with the Lcn972 resistant phenotype. The 270 
distinct phage resistant phenotype was further confirmed by the low adsorption of phage c2 to 271 
L. lactis D1, whereas in the case of sk1, adsorption to both Lcn972R mutants was not affected 272 
(Table 3).  273 
 274 
Impaired growth on maltose and lack of c2 infection is based on a chromosomal 275 
deletion detected in L. lactis D1 and D1-20 resistant to Lcn972. Prompted by the extreme 276 
resistance to phage c2 displayed by the L. lactis Lcn972R strains, we investigated further the 277 
molecular basis underlying this phenomenon. In the case of phage c2, the membrane protein 278 
Pip (Phage Infection Protein) is required for phage adsorption and DNA injection (14). 279 
Thereby, we aimed at identifying mutations in pip which might have occurred upon 280 
adaptation to Lcn972. However, attempts to amplify pip in L. lactis D1 and D1-20 by PCR 281 
failed, until a forward primer 0734F located 20.6 kbp upstream pip was used in combination 282 
with the reverse 0752R internal to pip. With these two primers, a 2.0 kbp PCR product was 283 
obtained on both L. lactis D1 and D1-20 DNAs. Sequencing of this PCR product revealed a 284 
large 22.6 kbp deletion expanding from llmg0736 to pip which was further confirmed by 285 
Southern hybridization (Fig. 3). This deletion encompassed genes involved in maltose 286 
metabolism, the two component system TCS F and the 5’ end of pip and explained both the 287 
impaired growth on maltose and the phage resistant phenotype based on the absence of a 288 
functional Pip protein.  289 
 290 
Contribution of deleted genes to Lcn972 antimicrobial activity. Experiments were 291 
carried out to confirm whether or not the genes included in the deleted region were directly 292 
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involved in Lcn972 resistance. When L. lactis MG1614 was growing on maltose, i.e. inducing 293 
maltose metabolic genes, the Lcn972 MIC was 20 AU/ml, differing in only one dilution step 294 
from the MIC in glucose (Table 4). Thus, activating maltose metabolism seems not to 295 
increase susceptibility to Lcn972 and a correlation to Lcn972 activity could not be 296 
established. On the other hand, the MIC of Lcn972 for L. lactis MGRrF which lacks the 297 
response regulator LlrF of TCS F was also two times more resistant than the wild type L. 298 
lactis (Table 4), pointing to a marginal role of this TCS in Lcn972 resistance.  299 
 300 
DISCUSSION 301 
The potent antimicrobial activity of bacteriocins has supported research for their application 302 
as food biopreservatives and as lead molecules for the design of new antibiotics. As 303 
development of resistance may impair their efficacy, subsequent studies have been addressed 304 
to understand the molecular basis of bacteriocin resistance and its impact in the physiology of 305 
otherwise susceptible bacteria. Mutants with different degrees of resistance towards 306 
bacteriocins may be easily selected under laboratory conditions after exposure to bacteriocins 307 
for several generations (3, 17, 19, 38). Mechanisms behind mostly involve changes at the cell 308 
envelope that precludes the bacteriocins to reach their target, mainly the plasma membrane. In 309 
this work, we have been able to isolate Lcn972R L. lactis mutants with reduced susceptibility 310 
to this cell wall active bacteriocin. As described for nisin (19), the acquired Lcn972 high 311 
resistant phenotype was lost quickly in the absence of selective pressure. Lcn972 is known to 312 
activate the two component system CesSR (26) whose regulon comprises other regulatory 313 
protein genes. Thereby, an adaptive response which may include CesR-mediated gen 314 
activation seemed to be involved in the Lcn972 high resistance phenotype. However, stable 315 
mutations have also occurred during selection because a stable resistant phenotype (8x MIC) 316 
could be maintained in the absence of Lcn972.  317 
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Resistance to Lcn972 did not strongly alter the overall surface properties of the cells. A 318 
common mechanism described for many cationic antimicrobial peptides including 319 
bacteriocins consists of D-alanylation of LTA (15, 20, 32) to decrease the negative charge and 320 
reduce the electrostastic interactions. However, in the case of Lcn972, it does not play a major 321 
role as no differences were observed both in the D-Ala content and the cell net charges. On 322 
the contrary, a remarkable change into the PG structure was observed. We could establish a 323 
direct correlation between the length of the peptide side chain and the susceptibility to 324 
Lcn972. Lcn972 resistant mutants had a reduced content of pentapeptide muropeptides. 325 
Moreover, L. lactis lacking the carboxypeptidase DacA and, consequently, with a high 326 
content of peptapeptide muropeptides, were more susceptible to Lcn972. Changes at the PG 327 
structure level has not been approached when studying bacteriocin resistance mutants. Thus, it 328 
is not possible to anticipate if this is a common mechanism of resistance among bacteriocins. 329 
Nevertheless, it is worth noting that enhanced susceptibility towards beta-lactam antibiotics 330 
and bacitracin, both targeting PG biosynthesis, has been previously linked to resistance to 331 
lipid II-binding bacteriocins (8, 19). Altered antimicrobial susceptibility has mostly been 332 
explained by the role of cell envelope enzymes (e.g. dlt operon and penicilling binding protein 333 
genes) in the response to cell envelope stress, specialized ABC exporters and specific and 334 
global regulators (7, 8, 19, 39). In the case of Lcn972, cross-protection to nisin and lysozyme 335 
might occur through the activation of CesSR or up-mutations in any of the CesR-regulated 336 
genes but the alteration of the PG could also be important. 337 
Another interesting result was the altered phage susceptibility profile of the Lcn972 338 
resistant mutants. Lack of infectivity of phage c2 was undoubtedly linked to the truncation of 339 
pip by the chromosomal deletion detected in the Lcn972 resistant strains. In fact, mutated 340 
versions of this protein have been previously correlated with resistance to c2 (28). On the 341 
other hand, the lower infectivity of sk1 remained unexplained. Resistance to sk1 has been 342 
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correlated with the absence of a polysaccharide pellicle in L. lactis MG1363 (6). However, the 343 
Lcn972 resistant strains have a similar gross carbohydrate composition than that of the wild 344 
type and also the pellicle was visible in the micrographs. Therefore, there must be some other 345 
as yet unidentified factors that compromise phage infectivity. Tentatively, the altered 346 
tripeptide/pentapeptide ratio in the PG of the Lcn972R strains could make it less susceptible to 347 
the phage endolysin, needed to release the phage progeny. Interestingly, sk1 plaques on the 348 
Lcn972R strains were consistently smaller (data not shown). 349 
The deletion found in the Lcn972 resistant strains was rather large and encompassed, 350 
besides pip, maltose metabolic genes and the two component system TCS F. Compelling data 351 
has been gathered connecting carbohydrate metabolism with resistance, namely to class IIa 352 
bacteriocins that target the mannose phosphotransferase system-PTSman (18, 36). Impaired 353 
growth on cellobiose has also been correlated with tolerance to Lcn972 in producing strains 354 
(5). However, our results indicated that maltose metabolism does not play a major role as cells 355 
are similarly susceptible, even slightly more resistant, when growing on maltose. On the other 356 
hand, TCS F has been reported to be relevant under oxidative stress (30). According to our 357 
results, only a minor role in Lcn972 resistance could be recognized. Therefore, there must be 358 
some other mutations that account for the Lcn972 resistant phenotype. In fact, the histidin 359 
kinase KinF has been reported to be essential (30) and it is likely that counter-mutations have 360 
been selected. Transcriptomic analyses are in progress in order to clarify the molecular basis 361 
underlying Lcn972 resistance.  362 
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FIGURE LEGENDS 504 
FIGURE 1 Distribution of muropeptides containing tri-, tetra- or pentapeptide side chains in 505 
the Lcn972 susceptible L. lactis MG1614 (white bars), Lcn972 resistant L. lactis D1 (grey 506 
bars) and L. lactis dacA (black bars). Values are the means of two independent peptidoglycan 507 
extractions, except for dacA mutant. Error bars indicate standard deviations.  508 
FIGURE 2 Susceptibility of L. lactis strains to cell wall active antimicrobials. (A) 509 
Susceptibility of different L. lactis cell envelope mutants to the bacteriocin Lcn972. Twofold 510 
dilutions of Lcn972 in sodium phosphate buffer 50 mM, pH 6.8 were spotted (5 µl) on L. 511 
lactis lawns. (B) Susceptibility of L. lactis MG1614 (WT) and the Lcn972 resistant strains L. 512 
lactis D1 and D1-20 to lysozyme (Lys), nisin (Nis), bacitracin (Bac) and penicillin G (PG). 513 
Ten-fold dilutions of overnight cultures (5 µl) were spotted on GM17 plates containing the 514 
indicated concentrations of the antimicrobials. 515 
FIGURE 3 Overview of the 22.6 kbp deletion found in L. lactis D1 and D1-20 resistant to 516 
Lcn972. A. Schematic drawing of L. lactis D1 deleted genes compared to L. lactis MG1614 517 
(WT). Gene annotation according to L. lactis MG1363 (GenBank AM406671). Only relevant 518 
EcoRI and HindIII sites are shown. Note that genes are not at scale. B. Confirmation of pip 519 
truncation (white arrow in A) by Southern blot using a PCR probe (black rectangle in A) and 520 
L. lactis DNA digested with HindIII and EcoRI.  521 
TABLE 1 Bacterial strains, bacteriophages, and plasmids used in this work. 
Strain, 
phage, or 
plasmid 
Descriptiona 
Reference/ 
source 
L. lactis   
MG1363 Plasmid-free and prophage-cured derivative of L. lactis NCDO712 13 
MG1614 StrR RifR derivative of MG1363, Lcn972S  13 
NZ9000 MG1363, carrying pepN::nisRK  21 
D1 MG1614, Lcn972 high resistant mutant, unstable This work 
D1-20 MG1614, Lcn972 low resistant mutant derived from D1, stable This work 
dacA NZ9000 lacking dacA gene This work 
dacB MG1363 lacking dacB gene 9 
dltD MG1363 lacking dltD gene 10 
MGRrF MG1363 pRV300::llrF 30 
E. coli   
DH10B Plasmid free, cloning host Invitrogen 
Phages   
c2 L. lactis lytic phage belonging to c2 family E. Bidnenko 
sk1 L. lactis lytic phage belonging to 936 family E. Bidnenko 
Plasmids   
pORI280 EmR, lacZ+, integrative plasmid 22 
pBL16 600 bp dacA flanking regions cloned in pORI208 This work 
a Str, streptomycin; Rif, rifampin; Em, erythromycin. 
TABLE 2 Properties of L. lactis MG1614 and its derivatives resistant to Lcn972 L. lactis D1 and 
L. lactis D1-20. 
L. lactis 
MIC 
Lcn972 
(AU/ml) 
µ (h-1)a 
Lcn972 
adsorption
(%) 
Adhesion to 
hexadecaneb 
(%) 
D-Ala 
(ng/mg dried cells) GM17 
 CDM 
 Glu Gal Mal 
MG1614 10 1.07  0.98 0.38 0.39 25.6 ± 3.1 75.75 ± 4.55 17.7 ± 2.7 
D1 >320 0.96  0.67 0.2 – 13.9 ± 0.8 62.90 ± 1.87 14.1 ± 0.6 
D1-20 80 0.97  0.68 0.37 – 14.4  ± 1.6 63.60 ± 1.74 14.3 ± 1.9 
 
a Growth was carried out in microtiter plates in GM17 or in tubes in chemically defined 
medium (CDM) supplemented with glucose (Glu), galactose (Gal) or maltose (Mal) at 0.5 %. 
b Determined by the MATS method. 
 TABLE 3 Phage activity on L. lactis MG1614 and the Lcn972 resistant derivatives L. 
lactis D1 and L. lactis D1-20. 
L. lactis 
Phage susceptibility 
EOPa  % Adsorption 
c2 sk1  c2 sk1 
MG1614 1.00 ± 0.00 1.00 ± 0.00  92.6 ± 4.8 88.9 ± 4.5 
D1 0 0.23 ± 0.06  43.6 ± 8.0 93.7 ± 4.5 
D1-20 0 0.60 ± 0.06  NDb 94.9 ± 0.7 
 
a EOP, efficiency of plaquing. 
b ND, not determined. 
 
 
 
 
 TABLE 4 Lcn972 minimum inhibitory concentration (MIC) for L. lactis strains 
L. lactis 
MIC (AU/ml) 
Glucose Maltose 
MG1614 10 20 
MGRrF 20 NDa 
a ND, not determined 
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